- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Allen Investment in Cell Biology on the Horizon?
4 October 2013 3:00 pm
Microsoft co-founder and philanthropic billionaire Paul Allen appears to have his sights on a new project focused on cell biology. At a 26 September symposium celebrating the Allen Institute for Brain Science’s 10th year, Allen called understanding cell biology “another holy grail” and admitted he was interested in developing a devoted institute, according to a Puget Sound Business Journal report. And in a recent interview with NBC News, Allen said he believes "it's the right time to start a big initiative in cell biology.”
ScienceInsider could not reach Allen for comment. But “Paul is certainly interested in it, and I think he confirmed it at our 10th anniversary,” says brain institute CEO Allan Jones. “But beyond that, it’s sort of still in the planning stages.”
Computational biologist Sean Eddy of the Howard Hughes Medical Institute's Janelia Farm Research Campus in Ashburn, Virginia, says he took part in a meeting of about 15 Allen Institute representatives and scientists in August to discuss the future of biology research, but that there was no mention of developing an institute. “We were talking about grandiose things,” Eddy says. “I got the feeling that he hadn’t really decided what the form of it would be,” he says of Allen’s possible investment. One central topic of discussion: whether the field of biology is best advanced by collecting massive data sets or by fostering small lab groups “doing experiments with their own hands, trying to find the sort of heart of something.”
Whether any new project would match the scale of the brain institute—launched with Allen’s $100 million investment, to which he added another $300 million last year—is yet to be seen.